Hepatitis Monthly

Published by: Kowsar

Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients

Alessio Aghemo 1 , Maria Grazia Rumi 2 , * , Sara Monico 1 , Matteo Banderali 1 , Antonio Russo 1 , Francesco Ottaviani 1 , Mauro Vigano 1 , Roberta DAmbrosio 1 and Massimo Colombo 1
Authors Information
1 A. M. Migliavacca Center for Liver Disease First, Division of Gastroenterology, IRCCS Fondazione Ca Granda Hospital, University of Milan, Italy
2 Department of Hepatology, St. Josephs Hospital, University of Milan, mariagrazia.rumi@unimi.it, Italy
Article information

To Cite: Aghemo A, Rumi M, Monico S, Banderali M, Russo A, et al. Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients, Hepat Mon. Online ahead of Print ; 11(11):918-924. doi: 10.5812/kowsar.1735143X.733.

Abstract
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments